Zaya1-8B is a huge shift in LLMs, and the results are impressive.

Six months after Anthropic shipped a plugin system for Claude Code, the most-installed extensions on the platform have ...

Recursion Pharmaceuticals exceeded EPS expectations by 15.38%. The company reported a significant revenue shortfall, missing forecasts by 60.26%. Pre-market stock price fell 1.84% amid broader biotech ...

Recursion Pharmaceuticals reported its first-quarter 2026 earnings, surpassing EPS expectations but missing revenue forecasts significantly. The company posted an EPS of -$0.22, better than the ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

The real headline is what ZAYA1-8B was trained on: a full stack of AMD Instinct MI300 graphics processing units (GPUs), the rival to Nvidia GPUs.

Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid tumors demonstrate a well-tolerated safety profile and ...

Earnings call Recursion Pharmaceuticals delivered strong operational progress with a 30% YoY reduction in operating expenses and an extended cash runway into early 2028. Clinical momentum was ...

Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid ...

EPS exceeded forecasts by 15.38%, reflecting effective cost management. Revenue missed expectations by 60.26%, raising concerns about growth prospects. The stock price fell by 5.34% in pre-market ...